Upregulation of FASN can increase the synthesis of SFA and MUFA, and high saturated levels of membrane lipids protect cancer cells from ROS-induced damage [13], thus preventing and repairing sorafenib induced lipid peroxidation and responsible for sorafenib resistance. Here, FASN is linked to cancer.